Global Cobalt-55 Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

According to our (Global Info Research) latest study, the global Cobalt-55 market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
In 2025, global Cobalt-55 production was approximately 335 grams, with an average global market price of around $18,000 per gram. That year, total global production capacity for Cobalt-55 reached approximately 600 grams, and the industry's average gross profit margin was about 56%. Cobalt-55 is an artificial radioactive isotope of the element cobalt, characterized by an atomic number of 27 and a mass number of 55. It is primarily produced via nuclear reactions in particle accelerators—for instance, by bombarding target materials such as nickel-54 (^54Ni) or iron-56 (^56Fe) with proton beams. Cobalt-55 has a relatively short half-life of approximately 17.5 hours; it decays primarily into iron-55 (^55Fe) through electron capture, a process accompanied by the emission of characteristic gamma-ray signals. Due to its favorable properties as a radioactive tracer and its detectable gamma-ray energy spectrum, Cobalt-55 is considered a promising radionuclide for medical imaging, particularly in research related to Positron Emission Tomography (PET).
The upstream segment of the Cobalt-55 industry chain encompasses the supply of high-purity target materials, particle accelerator equipment, nuclear reaction production systems, and radiochemistry laboratory infrastructure. Production typically involves the use of stable isotope target materials—such as high-purity nickel or iron—and relies on high-energy proton beams generated by cyclotrons to induce the necessary nuclear reactions. The isotopic purity, chemical stability, and thermal load tolerance of the target materials directly influence production efficiency and the final radiochemical purity of the Cobalt-55. In terms of equipment, the upstream sector involves medical cyclotrons, high-energy particle beam systems, target station assemblies, automated radioactive separation and purification equipment, and quality control instrumentation. Given the demanding technical requirements for Cobalt-55 production—which necessitate precise control over nuclear reaction conditions, irradiation times, and separation/purification workflows—manufacturers and research institutions generally require expertise in nuclear physics, radiochemistry, and isotope production. Furthermore, obtaining nuclear regulatory licenses, establishing radiation protection systems, and employing specialized technical personnel are essential prerequisites for entering this field. The midstream segment of the industry chain primarily comprises Cobalt-55 radionuclide producers, research institutions, and radiopharmaceutical R&D platforms. These entities typically utilize cyclotrons to produce Cobalt-55 and employ radiochemical processes—such as ion exchange, solvent extraction, and chromatographic separation—to obtain high-purity Cobalt-55 products that meet specific research and application standards. Cobalt-55 is primarily utilized in fields such as nuclear medicine imaging research, PET tracer development, tumor diagnostic research, and fundamental life sciences research. Possessing the characteristics of a metal element and emitting detectable radioactive signals, Cobalt-55 enables the development of cobalt-based complex tracers; it facilitates the study of metal ion metabolism in the human body and aids in analyzing the tumor microenvironment, protein expression, and changes in specific biological targets. In the medical field, Cobalt-55 is considered a key candidate radionuclide for the future development of various novel PET molecular probes, making it particularly suitable for research into radiopharmaceuticals that require metal coordination structures. Furthermore, Cobalt-55 holds potential for applications in areas such as precision tumor diagnosis, neurological and cardiovascular disease research, and the evaluation of drug mechanisms of action.
With the rapid advancement of precision medicine and molecular imaging technologies, the paradigm of nuclear medicine is shifting from traditional morphological detection toward precision diagnosis at the molecular level; this transition is a key driver for the development of Cobalt-55. As a PET radionuclide with metal coordination properties, Cobalt-55 enables the development of novel molecular tracers and holds potential for applications in areas such as tumor-targeted imaging, protein expression studies, metal metabolism analysis, and research into disease mechanisms. Compared to traditional PET radionuclides, Cobalt-55 can bind with a wide range of metal ligands, biomolecules, and targeted drug structures, offering new technical pathways for the precise localization and therapeutic assessment of complex diseases. Driven by the growing demand for early cancer screening, precision diagnosis, and personalized therapy, research institutions and pharmaceutical companies are increasing their investment in the R&D of novel PET radionuclides and innovative tracers, thereby laying the market foundation for the expanded application of Cobalt-55.
Secondly, the growth of the targeted radiopharmaceutical and nuclear medicine industries is accelerating the demand for Cobalt-55. In recent years, the global pharmaceutical industry has focused heavily on radionuclide-drug conjugates (RDCs), radioligand therapies (RLTs), and innovative nuclear medicines, fostering the development of a comprehensive industry chain that spans from diagnostic to therapeutic radionuclides. Although Cobalt-55 is currently primarily utilized in preclinical research and experimental phases, it offers unique advantages in the labeling of metal-based radiopharmaceuticals, the development of PET tracers, and pharmacokinetic evaluation. As more cobalt-complex tracers and novel nuclear medicines enter the R&D pipeline, Cobalt-55 is poised to become a significant complementary radionuclide in the fields of innovative molecular imaging and precision medicine.
Thirdly, advancements in cyclotron technology and enhanced radioisotope production capabilities provide the technical support necessary for the industrialization of Cobalt-55. Cobalt-55 is primarily produced artificially using cyclotrons, a process that demands high-purity target materials, precise control of high-energy particle beams, sophisticated radiochemical separation and purification techniques, and robust quality control capabilities. In recent years, the expansion of medical cyclotron networks and the accelerated construction of regional nuclear medicine centers have progressively improved the conditions for the localized production and application of short-lived radionuclides. At the same time, advancements in automated radiochemical synthesis equipment, target system optimization, and separation and purification technologies help improve Cobalt-55 production efficiency and reduce production losses, while facilitating the transition from a research-oriented supply model to a more stable, specialized supply model.
Report Scope
This report is a detailed and comprehensive analysis for global Cobalt-55 market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cobalt-55 market size and forecasts, in consumption value ($ Million), sales quantity (Gram), and average selling prices (US$/g), 2021-2032
Global Cobalt-55 market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Gram), and average selling prices (US$/g), 2021-2032
Global Cobalt-55 market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Gram), and average selling prices (US$/g), 2021-2032
Global Cobalt-55 market shares of main players, shipments in revenue ($ Million), sales quantity (Gram), and ASP (US$/g), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cobalt-55
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cobalt-55 market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include NIDC(DOE IP), AMT Isotopes, Cyclotron JSC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cobalt-55 market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Activity Concentration＜5mCi/mL
Activity Concentration≥5mCi/mL
Market segment by Chemical Form
Cobalt-55 Chloride
Cobalt-55 Labeled Compounds
Cobalt-55 Complex Radiopharmaceutical Precursor
Market segment by Purity Grade
Research-grade Cobalt-55
Clinical-grade Cobalt-55
Market segment by Production Method
Cyclotron
Nuclear Facility Production
Market segment by Application
Nuclear Medicine
Scientific Research
Major players covered
NIDC(DOE IP)
AMT Isotopes
Cyclotron JSC
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Cobalt-55 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cobalt-55, with price, sales quantity, revenue, and global market share of Cobalt-55 from 2021 to 2026.
Chapter 3, the Cobalt-55 competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cobalt-55 breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Cobalt-55 market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cobalt-55.
Chapter 14 and 15, to describe Cobalt-55 sales channel, distributors, customers, research findings and conclusion.